Long-term survival after coronary arterial grafts in patients with end-stage renal disease

Taro Nakatsu1, Nobushige Tamura, Yutaka Sakakibara

  • 1Department of Cardiovascular Surgery, Kumamoto Central Hospital, Kumamoto City, Japan. nakatsu-taro@hotmail.co.jp

Insights

Bilateral internal thoracic artery (BITA) grafting in end-stage renal disease (ESRD) patients undergoing coronary artery bypass grafting (CABG) showed no significant long-term survival benefit. However, BITA grafting may improve outcomes for ESRD patients without diabetes.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Transplantation

Background:

  • Bilateral internal thoracic artery (BITA) grafting is established to enhance long-term survival in coronary artery bypass grafting (CABG).
  • Limited data exists on BITA grafting efficacy in end-stage renal disease (ESRD) patients.
  • This study evaluates the potential benefits of BITA grafting specifically in the ESRD population.

Purpose of the Study:

  • To investigate the long-term outcomes of BITA grafting compared to single internal thoracic artery (SITA) grafting in ESRD patients.
  • To assess the impact of BITA grafting on survival rates, cardiac death, and cardiac events in this patient group.

Main Methods:

  • A retrospective analysis of 130 ESRD patients on chronic hemodialysis who underwent isolated CABG between 1988 and 2009.
  • Comparison of outcomes between 49 patients receiving BITA grafts and 81 patients receiving SITA grafts.
  • Mean follow-up duration of 5.2 ± 3.8 years.

Main Results:

  • No significant difference in mortality rates between BITA (4.1%) and SITA (4.9%) groups (p = 0.8215).
  • Similar incidences of mediastinitis and re-thoracotomy for bleeding were observed in both groups.
  • While long-term survival rates showed no statistical difference (p = 0.1636), BITA grafting demonstrated improved cardiac event outcomes in ESRD patients without diabetes (p = 0.0143).

Conclusions:

  • Coronary artery bypass grafting with BITA grafts does not offer significant long-term survival advantages for ESRD patients.
  • BITA grafting may be associated with improved long-term cardiac event outcomes in ESRD patients who do not have diabetes mellitus.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...